STMN STRAUMANN HOLDING AG

Invitation: Straumann Group 2023 first-quarter sales report webcast

Straumann Holding AG / Key word(s): Miscellaneous/Sales Result
Invitation: Straumann Group 2023 first-quarter sales report webcast

19.04.2023 / 15:00 CET/CEST


Date: Wednesday, May 3rd, 2023

Time: 10:30 – 11:30 a.m. CEST

 

Straumann Group will publish its 2023 first-quarter sales report on Wednesday, May 3rd, 2023, at approximately 7:00 a.m. CEST through the usual channels.

The live audio webcast is aimed at investors, financial analysts and journalists. The Group’s top management will review the performance and answer participants’ questions. The presentation and Q&A session will be held in English.

The webcast can be accessed via and a recording will be available afterwards.

If you intend to ask a question during the Q&A, we kindly ask you to pre-register for the conference call through this . We also recommend that you download the presentation file in advance using the direct link in the media release on before joining the conference call.

 

With kind regards
Straumann Group Corporate Communications & Investor Relations



End of Media Release


Language: English
Company: Straumann Holding AG
Peter Merian-Weg 12
4052 Basel
Switzerland
Phone:
Fax: 6
E-mail:
Internet: -group.com
ISIN: CH1175448666
Valor: 914326
Listed: SIX Swiss Exchange
EQS News ID: 1611955

 
End of News EQS News Service

1611955  19.04.2023 CET/CEST

fncls.ssp?fn=show_t_gif&application_id=1611955&application_name=news&site_id=research_pool
EN
19/04/2023

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on STRAUMANN HOLDING AG

Oliver Metzger
  • Oliver Metzger

Straumann Holding AG : Solid dental implant market, no relief in North...

The IDS confirmed our expectations for the dental implant market. North American dynamics are impacted by high interest rates and no short-term relief is expected. However, the mid- to long-term prospects are seen as positive. The valuation multiples already reflect the weakness in North America but the strong prospects for the other regions (72% of sales) are not included. We reiterate our Outperform rating with a reduced target price of CHF150 (from CHF163). Our lower estimates (2025 organic g...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch